Community-Based Health Insurance and Access to Medicines in Low-Income Countries
Author Information
Author(s): Catherine Vialle-Valentin, Dennis Ross-Degnan, Joseph Ntaganira, Anita K Wagner
Primary Institution: WHO Collaborating Center on Pharmaceutical Policy, Harvard Medical School
Hypothesis
Does Community-Based Health Insurance (CHI) improve access to medicines in low-income countries?
Conclusion
The study reveals a lack of evidence regarding medicines coverage in CHI, highlighting the need for systematic research to understand its impact on access and affordability.
Supporting Evidence
- Only 2% of respondents with voluntary insurance belong to the lowest income quintile.
- Medicines account for the largest component of out-of-pocket payments in low-income countries.
- Interviews indicated that medicines may represent up to 80% of CHI expenditures.
Takeaway
This study looks at how community health insurance can help people in poor countries get the medicines they need, but there isn't enough information to know if it's really working.
Methodology
The study used literature review, WHO National Health Accounts data, and structured interviews with CHI managers.
Potential Biases
Potential bias due to reliance on limited published data and self-reported information from CHI managers.
Limitations
The study highlights the scarcity of data on CHI and medicines coverage, making it difficult to draw firm conclusions.
Participant Demographics
The study focuses on low-income populations in various countries, including Rwanda and Lao PDR.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website